Anesthesia Considerations for a Patient on Semaglutide and Delayed Gastric Emptying
Анестезиологические аспекты ведения пациентки, принимающей семаглутид, при замедленном опорожнении желудка
2023-07-19
SCID: 54.1/gy3mbgww
Discuss with AI
Delayed gastric emptyingGlucagon-like peptide-1 receptor agonistsPreoperative fastingPulmonary aspirationSemaglutide
Figures from the paper
Abstract (AI)
Semaglutide is a class of long-acting glucagon-like peptide-1 receptor agonists (GLP1-RA) used for the treatment of type 2 diabetes mellitus (T2DM) and obesity. We present a 31-year-old female patient with a past medical history of T2DM without complication and no long-term or current use of insulin, class 3 obesity, hypertension, hyperlipidemia, polycystic ovary syndrome (PCOS), and anxiety, who underwent an esophagogastroduodenoscopy (EGD) in preparation for bariatric surgery while taking semaglutide. Despite appropriately following the preoperative fasting guidelines of the American Society of Anesthesiologists (ASA), endoscopy revealed food residue in the gastric body, necessitating abortion of the procedure to reduce the risk of intraoperative pulmonary aspiration. Given the lack of preoperative fasting guidelines for patients on semaglutide to date, and delayed gastric emptying being a known side effect among patients taking semaglutide, anesthesiologists should be aware of alternative methods to ensure no food is present in the stomach to mitigate the risk of pulmonary aspiration during general anesthesia.
Key Findings
1
A planned esophagogastroduodenoscopy was aborted because gastric residue increased concern for pulmonary aspiration during anesthesia.
2
Anesthesiologists should consider alternative methods to assess or ensure gastric emptying before general anesthesia in semaglutide-treated patients.
3
Semaglutide-associated delayed gastric emptying resulted in retained gastric food despite adherence to standard ASA preoperative fasting guidelines.
4
The case highlights the absence of established preoperative fasting guidelines specifically addressing patients taking semaglutide.
Research Object
A patient taking semaglutide undergoing esophagogastroduodenoscopy in preparation for bariatric surgery
Research Subject
Delayed gastric emptying and the associated risk of residual gastric contents and pulmonary aspiration during anesthesia despite standard preoperative fasting
Publication Details
Publication Date
2023-07-19
Journal
Publisher
ISSN
Cited by
83
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
Cited by8
Glucagon-Like Peptide-1 Receptor Agonist Use and Residual Gastric Content Before Anesthesia2024
Elective peri‐operative management of adults taking glucagon‐like peptide‐1 receptor agonists, glucose‐dependent insulinotropic peptide agonists and sodium‐glucose cotransporter‐2 inhibitors: a multidisciplinary consensus statement2025
A Scoping Review of GLP-1 Receptor Agonists: Are They Associated with Increased Gastric Contents, Regurgitation, and Aspiration Events?2024
The impact of glucagon-like peptide-1 receptor agonists in the patients undergoing anesthesia or sedation: systematic review and meta-analysis2024
Semaglutide and Postoperative Outcomes in Nondiabetic Patients Following Body Contouring Surgery2024
Emerging Anesthesia Risks with Semaglutide2023
GLP-1 Agonists and the Risk of Pulmonary Aspiration during Elective Upper Endoscopy: A Systematic Review and Meta-analysis2025
A preliminary study of the physiological and perceptual effects of GLP-1 receptor agonists during alcohol consumption in people with obesity2025